Owens & Minor Stock Price, News & Analysis
Company Description
Owens & Minor, Inc. (historically traded on the New York Stock Exchange under the ticker OMI) has undergone a significant corporate transformation and is now known as Accendra Health, Inc. According to the company’s SEC filings and press releases, the parent corporation changed its name from Owens & Minor, Inc. to Accendra Health, Inc., and its common stock is expected to trade on the New York Stock Exchange under the symbol ACH. The Articles of Amendment and amended bylaws changing the corporate name become effective at 11:59 p.m. Eastern Time on December 31, 2025, and the company expects trading under the new name and symbol to begin on January 2, 2026.
The company is incorporated in Virginia and has been described in multiple disclosures as a Fortune 500 global healthcare solutions company. Owens & Minor has stated that it provides essential products and services that support care from the hospital to the home. Over more than 100 years, Owens & Minor and its affiliated brands Apria, Byram, and HALYARD have been described as helping to make each day better for patients, providers, and communities. The company has highlighted that it is powered by a large global workforce and that it works behind the scenes so that healthcare can remain at the forefront.
In recent years, Owens & Minor has emphasized a strategic shift toward home-based care. The company has described itself as building a pure play home-based care platform and a pure-play Patient Direct business, with a focus on serving patients with chronic conditions in the home. Its Patient Direct segment includes the Apria and Byram Healthcare businesses, which are described as national leaders in home-based care. These brands provide products, services, and support intended to help improve health outcomes and the affordability of care in the home, and they serve patients with chronic and acute conditions.
Owens & Minor has reported that Apria and Byram together serve nearly three million patients each year and offer one of the broadest portfolios of products for chronic and acute conditions, including diabetes, sleep health, respiratory care, wound care, urology, and ostomy care. In a national agreement with Optum Health, Apria and Byram are described as preferred durable medical equipment (DME) network providers, offering patients a broad range of DME products in these categories to support care in the home.
Historically, Owens & Minor also operated a Products & Healthcare Services (P&HS) segment. This business has been described as a vertically integrated medical supply distribution platform primarily serving the acute care market, and as a national distributor of medical and surgical supplies for hospitals, health systems, and other healthcare providers across the United States. However, the company entered into an Equity Purchase Agreement to sell its P&HS segment, and an 8-K filed on December 31, 2025 reports the completion of the sale of the P&HS business to an affiliate of Platinum Equity for cash consideration, subject to customary adjustments, along with a retained equity interest. Following this transaction, the company has stated that it will be a pure play leader in the home-based care market with its focus centered on the Patient Direct platform.
The sale of the P&HS segment and the rebranding to Accendra Health are described by the company as key milestones in its strategic transformation. Management commentary in earnings releases and transaction announcements has emphasized that this transformation is intended to create a simpler, more focused organization centered on home-based care, with capital deployment, corporate strategy, and operational execution aligned around the Patient Direct business. The company has also indicated that it will continue to provide certain transition services to the buyer of the P&HS business under a transition services agreement.
From a capital markets perspective, Owens & Minor’s common stock has been registered under Section 12(b) of the Securities Exchange Act of 1934, with the class described as common stock with a par value per share. The company’s SEC filings list its Commission File Number as 001-09810 and its jurisdiction of incorporation as Virginia. The 8-K filings also reference various credit facilities, receivables purchase programs, and indentures, reflecting the company’s use of debt financing and receivables sale arrangements as part of its capital structure and liquidity management.
For investors researching the historical OMI ticker, it is important to recognize that this symbol is associated with Owens & Minor, Inc. prior to the name and symbol change. Current trading, filings, and market-related information for the continuing business are expected to be reported under the ACH symbol and the Accendra Health, Inc. name. The OMI symbol therefore primarily serves as a historical reference to the company’s legacy branding and its prior combination of hospital-focused distribution and home-based care operations.
Business focus and segments
Based on the company’s own descriptions, its continuing operations are centered on the Patient Direct platform and home-based care. The company has stated that its continuing operations primarily represent what was previously the Patient Direct segment and certain functional operations, especially after classifying the P&HS segment as discontinued operations in connection with the planned divestiture. Earnings releases describe Patient Direct as showing solid performance and growth, and management has highlighted long-term growth opportunities within home-based care.
The company has described Apria Healthcare LLC and Byram Healthcare Centers, Inc. as part of the Owens & Minor family and as national leaders in home-based care. Together, Apria and Byram make up the Patient Direct business segment and provide products and services for patients managing chronic and acute health needs in the home. The company’s disclosures indicate that these operations are supported by national scale and expertise, and that they work with large care organizations such as Optum Health to manage patients’ durable medical equipment needs at home.
Corporate evolution and strategic transformation
Owens & Minor has described a multi-year strategic move toward expanding its position in home-based care. The definitive agreement to divest the P&HS segment to Platinum Equity is characterized as a critical step in transforming the company into a pure-play home-based care platform. Following the completion of this sale, the company announced that it would rename the parent corporation to Accendra Health, Inc. and change its NYSE ticker symbol from OMI to ACH. In its public statements, the company has framed these actions as aligning its corporate identity with its strategic direction as a home-based care business.
The company has also reported various governance and organizational changes in connection with this evolution, including executive appointments and changes in responsibilities, as disclosed in Forms 8-K. These filings describe, for example, appointments to roles overseeing the Patient Direct segment and broader operational responsibilities, as well as amendments to certain executive compensation and retirement plans in light of the P&HS divestiture.
Historical context for OMI
Historically, Owens & Minor has been described as a Fortune 500 global healthcare solutions company serving both hospital and home settings. Earlier descriptions note that it provided essential products and services across the continuum of care, and that it operated through segments including Products & Healthcare Services and Patient Direct. The company’s long operating history and its role in supporting healthcare providers and patients have been emphasized in both corporate descriptions and transaction-related communications.
For users examining the OMI symbol on Stock Titan, the key context is that OMI refers to the company prior to its rebranding as Accendra Health and prior to the completion of the P&HS divestiture. The business associated with the legacy OMI symbol has evolved into a focused home-based care company whose ongoing public reporting and trading are expected to occur under the ACH ticker.
Key points for investors and researchers
- Corporate identity: Owens & Minor, Inc. has changed its corporate name to Accendra Health, Inc. pursuant to Articles of Amendment and amended bylaws, with effectiveness at the end of December 2025.
- Ticker symbol: The company’s common stock, previously traded under the symbol OMI on the New York Stock Exchange, is expected to trade under the symbol ACH.
- Strategic focus: The company describes itself as a pure play home-based care business centered on the Patient Direct platform, with Apria and Byram as key brands.
- Divestiture: The Products & Healthcare Services segment, which included a national medical and surgical supplies distribution business, has been sold to an affiliate of Platinum Equity, with Owens & Minor retaining a minority equity interest and certain tax attributes.
- Industry role: The company characterizes itself as providing essential products and services that support care from the hospital to the home, and as operating within the broader healthcare solutions and home-based care landscape.
Frequently asked questions about Owens & Minor (OMI)
Stock Performance
Owens & Minor (OMI) stock last traded at $2.80. Over the past 12 months, the stock has lost 78.6%. At a market capitalization of $216.6M, OMI is classified as a micro-cap stock with approximately 77.3M shares outstanding.
Latest News
Owens & Minor has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include conferences, earnings, acquisition. View all OMI news →
SEC Filings
Owens & Minor has filed 5 recent SEC filings, including 1 Form 4, 1 Form 10-K, 1 Form 8-K, 1 Form SCHEDULE 13G. The most recent filing was submitted on March 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OMI SEC filings →
Financial Highlights
Owens & Minor generated $2.8B in revenue over the trailing twelve months, retaining a 46.7% gross margin, operating income reached $27.5M (1.0% operating margin), and net income was -$1.1B, reflecting a -39.9% net profit margin. Diluted earnings per share stood at $-14.31. The company generated -$101.8M in operating cash flow. With a current ratio of 0.58, short-term liquidity bears monitoring.
Upcoming Events
Senior secured notes maturity
Owens & Minor has 1 upcoming scheduled event. The next event, "Senior secured notes maturity", is scheduled for April 15, 2030 (in 1483 days). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the OMI stock price.
Short Interest History
Short interest in Owens & Minor (OMI) currently stands at 9.0 million shares, down 10.3% from the previous reporting period, representing 12.1% of the float. Over the past 12 months, short interest has increased by 155.6%. This moderate level of short interest indicates notable bearish positioning.
Days to Cover History
Days to cover for Owens & Minor (OMI) currently stands at 4.8 days. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 81.3% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 2.2 to 8.4 days.
OMI Company Profile & Sector Positioning
Owens & Minor (OMI) operates in the Medical Distribution industry within the broader Wholesale-medical, Dental & Hospital Equipment & Supplies sector and is listed on the NYSE.
Investors comparing OMI often look at related companies in the same sector, including AKSO HEALTH GROUP (AHG), Quipt Home Medical Corp (QIPT), Edap Tms (EDAP), Henry Schein, Inc. (HSIC), and 111 (YI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OMI's relative position within its industry.